| Liquid biopsies come of age: towards implementation of circulating tumour DNA JCM Wan, C Massie, J Garcia-Corbacho, F Mouliere, JD Brenton, ... Nature Reviews Cancer 17 (4), 223-238, 2017 | 2384 | 2017 |
| Enhanced detection of circulating tumor DNA by fragment size analysis F Mouliere, D Chandrananda, AM Piskorz, EK Moore, J Morris, ... Science translational medicine 10 (466), eaat4921, 2018 | 901 | 2018 |
| Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA AR Thierry, F Mouliere, S El Messaoudi, C Mollevi, E Lopez-Crapez, ... Nature medicine 20 (4), 430-435, 2014 | 738 | 2014 |
| High fragmentation characterizes tumour-derived circulating DNA F Mouliere, B Robert, EA Peyrotte, M Del Rio, M Ychou, F Molina, ... PloS one 6 (9), e23418, 2011 | 639 | 2011 |
| Circulating cell free DNA: Preanalytical considerations S El Messaoudi, F Rolet, F Mouliere, AR Thierry Clinica Chimica Acta 424, 222-230, 2013 | 608 | 2013 |
| Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats S Arancibia, M Silhol, F Mouliere, J Meffre, I Höllinger, T Maurice, ... Neurobiology of disease 31 (3), 316-326, 2008 | 388 | 2008 |
| Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts AR Thierry, F Mouliere, C Gongora, J Ollier, B Robert, M Ychou, M Del Rio, ... Nucleic acids research 38 (18), 6159-6175, 2010 | 364 | 2010 |
| Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer F Mouliere, S El Messaoudi, D Pang, A Dritschilo, AR Thierry Molecular oncology 8 (5), 927-941, 2014 | 274 | 2014 |
| Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA Y Van Der Pol, F Mouliere Cancer Cell 36 (4), 350-368, 2019 | 264 | 2019 |
| Circulating tumor-derived DNA is shorter than somatic DNA in plasma F Mouliere, N Rosenfeld Proceedings of the National Academy of Sciences 112 (11), 3178-3179, 2015 | 181 | 2015 |
| Circulating DNA as a strong multimarker prognostic tool for metastatic colorectal cancer patient management care S El Messaoudi, F Mouliere, S Du Manoir, C Bascoul-Mollevi, B Gillet, ... Clinical Cancer Research 22 (12), 3067-3077, 2016 | 180 | 2016 |
| Circulating cell-free DNA from colorectal cancer patients may reveal high KRAS or BRAF mutation load F Mouliere, S El Messaoudi, C Gongora, AS Guedj, B Robert, M Del Rio, ... Translational oncology 6 (3), 319-IN8, 2013 | 173 | 2013 |
| ctDNA monitoring using patient-specific sequencing and integration of variant reads JCM Wan, K Heider, D Gale, S Murphy, E Fisher, F Mouliere, ... Science translational medicine 12 (548), eaaz8084, 2020 | 161 | 2020 |
| Detection of cell‐free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients F Mouliere, R Mair, D Chandrananda, F Marass, CG Smith, J Su, J Morris, ... EMBO molecular medicine 10 (12), e9323, 2018 | 155 | 2018 |
| The importance of examining the proportion of circulating DNA originating from tumor, microenvironment and normal cells in colorectal cancer patients F Mouliere, AR Thierry Expert opinion on biological therapy 12 (sup1), S209-S215, 2012 | 128 | 2012 |
| The value of cell‐free DNA for molecular pathology CM Stewart, PD Kothari, F Mouliere, R Mair, S Somnay, R Benayed, ... The Journal of pathology 244 (5), 616-627, 2018 | 127 | 2018 |
| Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer KM Patel, KE van der Vos, CG Smith, F Mouliere, D Tsui, J Morris, ... Scientific Reports 7, 2017 | 107 | 2017 |
| Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors CG Smith, T Moser, F Mouliere, J Field-Rayner, M Eldridge, AL Riediger, ... Genome medicine 12, 1-17, 2020 | 96 | 2020 |
| Measurement of Plasma Cell-Free Mitochondrial Tumor DNA Improves Detection of Glioblastoma in Patient-Derived Orthotopic Xenograft Models R Mair, F Mouliere, CG Smith, D Chandrananda, D Gale, F Marass, ... Cancer research 79 (1), 220-230, 2019 | 89 | 2019 |
| Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer E Heitzer, D van den Broek, MG Denis, P Hofman, M Hubank, F Mouliere, ... ESMO Open 7 (2), 100399, 2022 | 82 | 2022 |
Nitzan RosenfeldCancer Research UK Cambridge Institute and University of CambridgeΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα cruk.cam.ac.uk
